References
Original article
Stimming, E. F. et al. Safety and efficacy of valbenazine for the treatment of chorea associated with Huntington’s disease (KINECT-HD): a phase 3, randomised, double-blind, placebo-controlled trial. Lancet Neurol. 22, 494–504 (2023)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wood, H. A new drug to treat chorea in Huntington disease. Nat Rev Neurol 19, 387 (2023). https://doi.org/10.1038/s41582-023-00832-z
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41582-023-00832-z
- Springer Nature Limited
This article is cited by
-
Exploring molecular mechanisms, therapeutic strategies, and clinical manifestations of Huntington’s disease
Archives of Pharmacal Research (2024)